^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SCRI-CAR22v2

i
Associations
Company:
Seattle Children's Hospital
Drug class:
CD22-targeted CAR-T immunotherapy
Related drugs:
Associations
Phase 1/2
Seattle Children's Hospital
Recruiting
Last update posted :
04/09/2024
Initiation :
09/25/2020
Primary completion :
06/01/2025
Completion :
02/01/2040
CD22
|
SCRI-CAR22v2